FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

9157211000001101: Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 05-Sep 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    30344701000001111 Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    54592201000001111 Co-careldopa 50mg/200mg modified-release tablets (Alliance Healthcare (Distribution) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) Is a Carbidopa + levodopa 50mg/200mg m/r tablet false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) Has active ingredient Carbidopa false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) Has active ingredient Levodopa false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Carbidopa false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) Has specific active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) Has specific active ingredient Levodopa false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) Has dispensed dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) Is a Actual medicinal product false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) Has specific active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) Has basis of strength substance Carbidopa false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) 60 tablet Is pack of False Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) 60 tablet Has AMP False Co-careldopa 50mg/200mg modified-release tablets (Unichem Plc) Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start